0001127602-22-008037.txt : 20220303 0001127602-22-008037.hdr.sgml : 20220303 20220303165829 ACCESSION NUMBER: 0001127602-22-008037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meline David W CENTRAL INDEX KEY: 0001444612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 22709963 MAIL ADDRESS: STREET 1: 3M COMPANY STREET 2: 3M OFFICE OF GENERAL COUNSEL CITY: ST PAUL STATE: MN ZIP: 55144-1000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-03-01 0001682852 Moderna, Inc. MRNA 0001444612 Meline David W C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Financial Officer Stock Option (Right to Buy) 149.52 2022-03-01 4 A 0 26020 0 A 2023-03-01 2032-03-01 Common Stock 26020 26020 D Restricted Stock Units 0 2022-03-01 4 A 0 6415 0 A Common Stock 6415 6415 D 25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2022-03-03